New Delhi [India], January 2: Pharmaceutical industry plays a pivotal role in global healthcare, focusing on the development, production, and distribution of medications that improve and save lives. With an ever-evolving landscape driven by scientific advancements, this industry is crucial i
Gurgaon (Haryana) [India], November 6: Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise today announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosm
The National Pharmaceutical Pricing Authority (NPPA) on Wednesday fixed the retail price of 20 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013.
The centre waived local clinical trials of several drugs in India. According to the official sources, the medicines already approved by other regulatory authorities like the US, UK and EU and are not immediately available for India are not required to conduct local trials in India.
Mumbai (Maharashtra) [India], January 31: Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated, clinical-stage biotech subsidiary, today announced the launch of their alliance - Ich
Bengaluru (Karnataka) [India], December 15: The U.S. Food and Drug Administration (FDA) has approved Lyrus Life Sciences's Abbreviated New Drug Application (ANDA) for 'Methenamine Hippurate Tablets USP, 1 gram', an AB-rated, substitutable generic version of Hiprex® from Validus Pharmace
Bangalore (Karnataka) [India], November 29: Foundation for Neglected Disease Research (FNDR) is proud to announce that its partners, Bill & Melinda Gates Medical Research Institute and TB Alliance, have successfully completed the Phase 2A Early Bactericidal Activity clinical trial of TBA
A recent study revealed that when normal therapy fails, a medicine called XEN1101 reduces seizure frequency by more than 50 per cent in certain individuals and sometimes removes them entirely. Unlike other treatments that must be started at low dosages and gradually increased, the new medici
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
Researchers discovered new drug development targets as well as potential urine tests. The findings were published in the journal, 'Journal of Clinical Investigation.'
Researchers found cancer cells can adapt to new drugs called CDK2 inhibitors in 1-2 hours, but adding a second drug squelches the workaround. The study was published in Journal, 'Cell.'